Fertility and Sterility
Volume 94, Issue 1 , Pages 126-129 , June 2010

Genetic testing of sperm donors: survey of current practices

  • Charles A. Sims, M.D.

      Affiliations

    • California Cryobank, Inc
    • ,
  • Pamela Callum, M.S., C.G.C.

      Affiliations

    • California Cryobank, Inc
    • Corresponding Author InformationReprint requests: Pamela Callum, M.S., C.G.C., Genetics Department, California Cryobank, Inc., 11925 La Grange Avenue, Los Angeles, CA 90025 (FAX: 310-744-0112).
    • ,
  • Marilyn Ray, M.P.H.

      Affiliations

    • California Cryobank, Inc
    • ,
  • Jennifer Iger, M.S.

      Affiliations

    • California Cryobank, Inc
    • ,
  • Rena E. Falk, M.D.

      Affiliations

    • Cedars Sinai Medical Center, Los Angeles, California

Received 8 November 2008 ,Revised 12 January 2009 ,Accepted 24 January 2009.

References 

  1. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004;6:387–391
  2. Gross SJ, Pletcher BA, Monagha KG. Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med. 2008;10:54–56
  3. The Practice Committee of the American Society for Reproductive Medicine and the Practice Committee of the Society for Assisted Reproductive Technology. 2006 Guidelines for gamete and embryo donation: guidelines and minimum standards. Fertil Steril. 2006;86:S38–S50
  4. Prior TS. Carrier screening for spinal muscular atrophy. Genet Med. 2008;10:870–872
  5. ACMG Laboratory Practice Committee Working Group. ACMG recommendations for standards for interpretation of sequence variations. Genet Med. 2000;5:302–303
  6. American College of Medical Genetics Professional Practice and Guidelines Committee. Statement on population screening for BRCA-1 mutation in Ashkenazi JewisSh women. ACMG Newsletter. 1996;7:9
  7. Conrad EA, Fire B, Hecht BR, Pergament E. Current practices of commercial cryobanks in screening prospective donors for genetic disease and reproductive risk. Int J Fertil Menopausal Stud. 1996;41:298–303

 C.A.S. is the Medical Director and owner of California Cryobank. P.C. has nothing to disclose. M.R. has nothing to disclose. J.I. has nothing to disclose. R.E.F. has nothing to disclose.

PII: S0015-0282(09)00263-5

doi: 10.1016/j.fertnstert.2009.01.139

Fertility and Sterility
Volume 94, Issue 1 , Pages 126-129 , June 2010

Article Tools